Akero Therapeutics, Inc. Business Finance Contracts & Agreements

20 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Akero Therapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Akero Therapeutics, Inc.
Biotechnology
2025
Akero Therapeutics, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
Warrant Agreements
Akero Therapeutics, Inc.
Biotechnology
NY
2025
Underwriting Agreement between Akero Therapeutics, Inc. and J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, and Jefferies LLC (January 28, 2025)
Underwriting Agreements
Akero Therapeutics, Inc.
Biotechnology
NY
2025
Warrant Agreement to Purchase Common Stock of Akero Therapeutics, Inc. by Hercules Private Credit Fund 1 L.P.
Warrant Agreements
Akero Therapeutics, Inc.
Biotechnology
CA
2024
Warrant Agreement between Akero Therapeutics, Inc. and Hercules Private Credit Fund 1 L.P. dated March 12, 2024
Warrant Agreements
Akero Therapeutics, Inc.
Biotechnology
CA
2024
Akero Therapeutics, Inc. Underwriting Agreement for 11,000,000 Shares of Common Stock (March 2024)
Underwriting Agreements
Akero Therapeutics, Inc.
Biotechnology
NY
2024
Underwriting Agreement between Akero Therapeutics, Inc. and Jefferies LLC for Sale of Common Stock
Underwriting Agreements
Akero Therapeutics, Inc.
Biotechnology
NY
2023
Open Market Sale Agreement between Akero Therapeutics, Inc. and Jefferies LLC (March 17, 2023)
Equity Distribution Agreements
Akero Therapeutics, Inc.
Biotechnology
NY
2023
Underwriting Agreement between Akero Therapeutics, Inc. and J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, and Jefferies LLC (September 14, 2022)
Underwriting Agreements
Akero Therapeutics, Inc.
Biotechnology
NY
2022
Warrant Agreement between Akero Therapeutics, Inc. and Hercules Capital, Inc. dated June 15, 2022
Warrant Agreements
Akero Therapeutics, Inc.
Biotechnology
CA
2022
Warrant Agreement between Akero Therapeutics, Inc. and Hercules Private Global Venture Growth Fund I L.P. dated June 15, 2022
Warrant Agreements
Akero Therapeutics, Inc.
Biotechnology
CA
2022
Underwriting Agreement between Akero Therapeutics, Inc. and Underwriters (J.P. Morgan, Morgan Stanley, Jefferies, Evercore) for Common Stock Offering
Underwriting Agreements
Akero Therapeutics, Inc.
Biotechnology
NY
2020
Description of Akero Therapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Registration Rights Agreements
Akero Therapeutics, Inc.
Biotechnology
2020
Akero Therapeutics, Inc. 2019 Employee Stock Purchase Plan
Stock Agreements
Akero Therapeutics, Inc.
Biotechnology
DE
2019
Underwriting Agreement between Akero Therapeutics, Inc. and J.P. Morgan Securities LLC, Jefferies LLC, and Evercore Group L.L.C.
Underwriting Agreements
Akero Therapeutics, Inc.
Biotechnology
NY
2019
Akero Therapeutics, Inc. 2018 Stock Option and Grant Plan
Stock Agreements
Akero Therapeutics, Inc.
Biotechnology
DE
2019
Amended and Restated Investors' Rights Agreement among Akero Therapeutics, Inc. and Investors (December 5, 2018)
Investor Rights Agreements
Akero Therapeutics, Inc.
Biotechnology
DE
2019
Second Amendment to Loan and Security Agreement by and among Akero Therapeutics, Inc., Hercules Capital, Inc., and Lenders
Loan Agreements
Akero Therapeutics, Inc.
Biotechnology
CA
2024
Loan and Security Agreement among Akero Therapeutics, Inc., Hercules Capital, Inc., and Lenders (June 15, 2022)
Loan Agreements
Akero Therapeutics, Inc.
Biotechnology
CA
2022
Securities Purchase Agreement between Akero Therapeutics, Inc. and Pfizer Inc. dated June 15, 2022
Purchase Agreements
Akero Therapeutics, Inc.
Biotechnology
NY
2022